Application and development of implantable biventricular assist devices
10.3760/cma.j.cn112434-20240606-00153
- VernacularTitle:双心室辅助装置发展的思考
- Author:
Nianguo DONG
1
;
Shunzhou YU
Author Information
1. 华中科技大学同济医学院附属协和医院心脏大血管外科，武汉 430022
- Keywords:
End-stage heart failure;
Implantable biventricular assist device
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2024;40(8):449-450
- CountryChina
- Language:Chinese
-
Abstract:
Approximately 30% of end-stage heart failure patients suffer from biventricular heart failure, and the incidence of severe right ventricular failure in patients after left ventricular assist device (LVAD) implantation ranges from 10%-30%. Although ventricular assist devices are primarily used to treat left ventricular failure, biventricular assist can be employed to address biventricular heart failure or right ventricular failure following LVAD implantation. With the breakthrough of the third-generation full magnetic levitation technology, the implantable biventricular assist device (BiVAD) has provided better therapeutic outcomes than the earlier pulsatile BiVAD and total artificial heart. This article aims to analyze and prospect the development trends of BiVAD, and introduces the design concept of the new generation BiVAD product D-uoCor with independent intellectual property rights, elaborating its technical features and clinical value.
